(Press-News.org) AWARD-winning research by a transport and logistics expert at the University of Huddersfield has shown that there would be economic and environmental benefits to individual companies and the country if the UK changed the rules to allow high capacity vehicles (HCVs) on to its roads.
At 25.25 metres, they would be around a third as long again as the largest lorries currently permitted in Britain. But they would NOT carry heavier loads. They would be used for larger quantities of lightweight goods, therefore cutting down the number of vehicle journeys made, leading to significant cost savings, reduced carbon emissions and a lessening of congestion.
David Leach has now completed a detailed report into what is a highly-controversial topic. A paper based on his work was judged to be the best at the recent Annual Conference of the Logistics Research Network. Mr Leach's focus is purely on extended vehicle length, while maintaining gross weight at the current UK standard, and this makes his research unique. Other studies have looked at increasing both weight and length simultaneously.
The report is published by the University of Huddersfield (see electronic version at http://eprints.hud.ac.uk/15769/) and when it lands on the desks of politicians, lobbyists and specialist journalists it could help re-open a vexed debate.
"I think that in the right circumstances, for companies that transport lightweight goods in large quantities, from distribution site to distribution site, HCVs would be an undoubted benefit and would lead to a reduction in carbon emissions," argues Mr Leach, who held senior positions in the logistics industry before switching to an academic career as a lecturer and researcher, specialising in freight transport and supply chain finance.
The rail-freight industry – fearing a wholesale switch to road transport – and safety campaigners – who are fearful of larger vehicles – have been rigidly opposed to larger vehicles in Britain. But David Leach's findings run counter to many of their arguments.
He believes that only a small proportion of freight traffic is at risk of transfer from rail to HCVs, which are unsuited for heavy goods such as steel, coal and aggregates. European studies have shown that extra large vehicles do not create additional road safety problems and technical innovations mean that HCVs are equally as manoeuvrable as their smaller counterparts; and if their 50 per cent greater carrying capacity leads to fewer vehicles on the road, they could cut congestion.
Currently, the maximum permitted length of freight vehicles on UK roads is 18.75 metres for a drawbar combination vehicle – a lorry plus trailer. But some European countries – notably the Netherlands – have exercised the right to opt out of the EU norm within their own boundaries and have permitted vehicles of up to 25.25 metres.
Crucially, although HCVs are longer and have a higher capacity, they would not be permitted to exceed the current maximum weight when loaded – 44 tonnes in the UK.
"You are increasing the cubic capacity of the vehicle but you are reducing the maximum weight of goods that it can carry," explains Mr Leach. "This means that HCVs will only be of value to companies that distribute lightweight goods, such as snack foods, tissues and packaging materials."
David Leach's research was commissioned by Kimberly-Clark, the multi-national firm that manufactures a range of personal and health care products.
Mr Leach, who worked on the research with his colleague Chris Savage, estimated that about 15 per cent of the UK's standard full-load traffic would be suitable for HCVs. This means that it is a niche market, but the numbers would still be significant.
Full adoption in the UK could lead to annual transport cost savings of £226 million, states the report. Total reductions in carbon emissions could amount to 96 thousand tonnes per annum and the use of HCVs would reduce the total distances travelled by large vehicles by up to 4 per cent, making a useful contribution to the relief of congestion.
### END
High capacity vehicles the future?
2012-11-09
ELSE PRESS RELEASES FROM THIS DATE:
A new way of making glass
2012-11-09
When cooling a liquid below its melting temperature it either crystallizes or transforms into a glass. Glass is a peculiar state of matter: it has the mechanical properties of a solid but an amorphous structure like a liquid.
As long ago as 1952, Sir Charles Frank at the University of Bristol argued that the structure of glasses should not be entirely disordered like a liquid but rather that it should be filled with polyhedra like the bicapped square antiprism.
Although such motifs have very recently been found in experiments and computer simulations on glassy materials, ...
Super storm tracked by European Space Agency water mission
2012-11-09
When millions of people are bracing themselves for the onslaught of extreme weather, as much information as possible is needed to predict the strength of the impending storm. ESA's SMOS mission again showed its versatility by capturing unique measurements of Hurricane Sandy.
As its name suggests, the Soil Moisture and Ocean Salinity (SMOS) satellite was designed to measure how much moisture is held in soil and how much salt is held in the surface waters of the oceans.
This information is helping to improve our understanding of the water cycle – an essential component ...
A scientific explanation to why people perform better after receiving a compliment
2012-11-09
A team of Japanese scientists have found scientific proof that people doing exercises appear to perform better when another person compliments them. The research was carried out by a group lead by National Institute for Physiological Sciences Professor Norihiro Sadato, Graduate University for Advanced Studies graduate student Sho Sugawara, Nagoya Institute of Technology Tenure-Track Associate Professor Satoshi Tanaka, and in collaboration with Research Center for Advanced Science and Technology Associate Professor Katsumi Watanabe. The team had previously discovered that ...
Understanding antibiotic resistance using crystallography and computation
2012-11-09
Increasingly, bacteria such as E. coli are resisting the action of carbapenems by producing enzymes (carbapenemases) that break a specific chemical bond in the antibiotic, destroying its antimicrobial activity.
Carbapenemases are members of the group of enzymes called beta-lactamases that break down penicillins and related antibiotics, but it has not been clear why carbapenemases can destroy carbapenems while other beta-lactamases cannot.
Using molecular dynamics simulations, Professor Adrian Mulholland in the School of Chemistry and Dr Jim Spencer in the School of ...
ADHD medicine affects the brain's reward system
2012-11-09
A group of scientists from the University of Copenhagen has created a model that shows how some types of ADHD medicine influence the brain's reward system. The model makes it possible to understand the effect of the medicine and perhaps in the longer term to improve the development of medicine and dose determination. The new research results have been published in the Journal of Neurophysiology.
In Denmark approximately 2-3 per cent of school-age children satisfy diagnostic criteria for ADHD, and therefore it is crucial to know how the medicine works. With a new mathematical ...
New mechanism of action for PARP inhibitors discovered
2012-11-09
PHILADELPHIA — New understanding of how drugs called PARP inhibitors, which have already shown promise for the treatment of women with familial breast and ovarian cancers linked to BRCA mutations, exert their anticancer effects has led to the identification of ways in which the patient population that might benefit from PARP inhibitors could be expanded.
Yves Pommier, M.D., Ph.D., chief of the Laboratory of Molecular Pharmacology at the National Cancer Institute's Center for Cancer Research in Bethesda, Md., and colleagues reported these data in Cancer Research, a journal ...
Link found between child prodigies and autism
2012-11-09
COLUMBUS, Ohio - A new study of eight child prodigies suggests a possible link between these children's special skills and autism.
Of the eight prodigies studied, three had a diagnosis of autism spectrum disorders. As a group, the prodigies also tended to have slightly elevated scores on a test of autistic traits, when compared to a control group.
In addition, half of the prodigies had a family member or a first- or second-degree relative with an autism diagnosis.
The fact that half of the families and three of the prodigies themselves were affected by autism is surprising ...
Study questions the relevance of SCIP benchmarks among CABG patients
2012-11-09
(Boston) – Cardiothoracic surgeons and endocrinologists from Boston Medical Center (BMC) have found that among patients undergoing coronary artery bypass graft (CABG) surgery, achieving Surgical Care Improvement Project (SCIP) benchmarks for glycemic control may be irrelevant when perioperative continuous insulin infusion protocols are implemented. These findings appear on-line in the Journal of Thoracic and Cardiovascular Surgery.
Currently, 40 percent of all patients undergoing CABG suffer from diabetes, and this number is quickly rising. Traditionally these patients ...
Belatacept after a kidney transplant: Minor added benefit for certain patients
2012-11-09
Belatacept (trade name Nulojix®) has been approved since June 2011 to prevent a rejection reaction of the body to the donor organ (transplant) in adults who have received a kidney transplant. The Institute for Quality and Efficiency in Health Care (IQWiG) has examined the added benefit of the drug pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG).
The assessment showed an indication of a minor added benefit of belatacept in adults with transplants from donors who had been selected according to the so-called standard criteria. Serious side ...
Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
2012-11-09
Researchers at Moffitt Cancer Center have identified metabolic signatures that may pave the way for personalized therapy in glioma, a type of tumor that starts in the brain.
The study appears online in the October issue of Cancer Research, a publication of the American Association for Cancer Research.
According to the authors, little has been known about the underlying metabolic alterations that may drive the growth of the most aggressive type of glioma, termed glioblastoma.
"For the first time, we have described global metabolomic signatures in glioma," said study ...